A recent study did not detect an effect of the G84E mutation on interaction with MEIS1 (Johng et al., 2019), suggesting alternative mechanisms for HOXB13 mutations in driving prostate carcinogenesis beyond disruption of MEIS interaction. Here, HOXB13 is linked to urogenital neoplasm.